| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.371 | 5.338 | 6.369 | 4.768 | 4.237 | 955 | 3.002 | 7.661 | 1.023 | 251 |
| Total Income - EUR | 5.371 | 5.338 | 6.369 | 4.768 | 4.237 | 955 | 3.002 | 7.661 | 1.023 | 251 |
| Total Expenses - EUR | 1.525 | 2.969 | 1.683 | 2.727 | 2.313 | 1.822 | 974 | 11.815 | 2.902 | 2.537 |
| Gross Profit/Loss - EUR | 3.847 | 2.368 | 4.686 | 2.042 | 1.924 | -867 | 2.028 | -4.155 | -1.879 | -2.286 |
| Net Profit/Loss - EUR | 3.685 | 2.208 | 4.495 | 1.899 | 1.797 | -896 | 1.940 | -4.380 | -1.879 | -2.286 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Codriamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.126 | 5.415 | 4.118 | 2.859 | 1.644 | 474 | 0 | 5.392 | 3.471 | 1.558 |
| Current Assets | 270 | 488 | 4.215 | 7.236 | 10.055 | 10.103 | 12.263 | 2.194 | 2.212 | 1.807 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 12 | 12 |
| Cash | 270 | 488 | 4.215 | 7.236 | 10.055 | 10.103 | 12.263 | 2.182 | 2.200 | 1.795 |
| Shareholders Funds | 1.615 | 3.806 | 8.237 | 9.984 | 11.588 | 10.473 | 12.180 | 7.549 | 5.647 | 3.329 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.781 | 2.096 | 97 | 111 | 111 | 105 | 83 | 37 | 36 | 36 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Codriamed S.r.l.